Cargando…
Spirometry and Bronchodilator Test
Spirometry is a physiological test for assessing the functional aspect of the lungs using an objective indicator to measure the maximum amount of air that a patient can inhale and exhale. Acceptable spirometry testing needs to be conducted three times by an acceptable and reproducible method for det...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392482/ https://www.ncbi.nlm.nih.gov/pubmed/28416951 http://dx.doi.org/10.4046/trd.2017.80.2.105 |
_version_ | 1783229452957777920 |
---|---|
author | Sim, Yun Su Lee, Ji-Hyun Lee, Won-Yeon Suh, Dong In Oh, Yeon-Mok Yoon, Jong-seo Lee, Jin Hwa Cho, Jae Hwa Kwon, Cheol Seok Chang, Jung Hyun |
author_facet | Sim, Yun Su Lee, Ji-Hyun Lee, Won-Yeon Suh, Dong In Oh, Yeon-Mok Yoon, Jong-seo Lee, Jin Hwa Cho, Jae Hwa Kwon, Cheol Seok Chang, Jung Hyun |
author_sort | Sim, Yun Su |
collection | PubMed |
description | Spirometry is a physiological test for assessing the functional aspect of the lungs using an objective indicator to measure the maximum amount of air that a patient can inhale and exhale. Acceptable spirometry testing needs to be conducted three times by an acceptable and reproducible method for determining forced vital capacity (FVC). Until the results of three tests meet the criteria of reproducibility, the test should be repeated up to eight times. Interpretation of spirometry should be clear, concise, and informative. Additionally, spirometry should guarantee optimal quality prior to the interpreting spirometry results. Our guideline adopts a fixed normal predictive value instead of the lower limit of normal as the reference value because fixed value is more convenient and also accepts FVC instead of vital capacity (VC) because measurement of VC using a spirometer is impossible. The bronchodilator test is a method for measuring the changes in lung capacity after inhaling a short-acting β-agonist that dilates the airway. When an obstructive ventilatory defect is observed, this test helps to diagnose and evaluate asthma and chronic obstructive pulmonary disease by measuring reversibility with the use of an inhaled bronchodilator. A positive response to a bronchodilator is generally defined as an increase of ≥12% and ≥200 mL as an absolute value compared with a baseline in either forced expiratory volume at 1 second or FVC. |
format | Online Article Text |
id | pubmed-5392482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
record_format | MEDLINE/PubMed |
spelling | pubmed-53924822017-04-17 Spirometry and Bronchodilator Test Sim, Yun Su Lee, Ji-Hyun Lee, Won-Yeon Suh, Dong In Oh, Yeon-Mok Yoon, Jong-seo Lee, Jin Hwa Cho, Jae Hwa Kwon, Cheol Seok Chang, Jung Hyun Tuberc Respir Dis (Seoul) Review Spirometry is a physiological test for assessing the functional aspect of the lungs using an objective indicator to measure the maximum amount of air that a patient can inhale and exhale. Acceptable spirometry testing needs to be conducted three times by an acceptable and reproducible method for determining forced vital capacity (FVC). Until the results of three tests meet the criteria of reproducibility, the test should be repeated up to eight times. Interpretation of spirometry should be clear, concise, and informative. Additionally, spirometry should guarantee optimal quality prior to the interpreting spirometry results. Our guideline adopts a fixed normal predictive value instead of the lower limit of normal as the reference value because fixed value is more convenient and also accepts FVC instead of vital capacity (VC) because measurement of VC using a spirometer is impossible. The bronchodilator test is a method for measuring the changes in lung capacity after inhaling a short-acting β-agonist that dilates the airway. When an obstructive ventilatory defect is observed, this test helps to diagnose and evaluate asthma and chronic obstructive pulmonary disease by measuring reversibility with the use of an inhaled bronchodilator. A positive response to a bronchodilator is generally defined as an increase of ≥12% and ≥200 mL as an absolute value compared with a baseline in either forced expiratory volume at 1 second or FVC. The Korean Academy of Tuberculosis and Respiratory Diseases 2017-04 2017-03-31 /pmc/articles/PMC5392482/ /pubmed/28416951 http://dx.doi.org/10.4046/trd.2017.80.2.105 Text en Copyright©2017. The Korean Academy of Tuberculosis and Respiratory Diseases http://creativecommons.org/licenses/by-nc/4.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Review Sim, Yun Su Lee, Ji-Hyun Lee, Won-Yeon Suh, Dong In Oh, Yeon-Mok Yoon, Jong-seo Lee, Jin Hwa Cho, Jae Hwa Kwon, Cheol Seok Chang, Jung Hyun Spirometry and Bronchodilator Test |
title | Spirometry and Bronchodilator Test |
title_full | Spirometry and Bronchodilator Test |
title_fullStr | Spirometry and Bronchodilator Test |
title_full_unstemmed | Spirometry and Bronchodilator Test |
title_short | Spirometry and Bronchodilator Test |
title_sort | spirometry and bronchodilator test |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392482/ https://www.ncbi.nlm.nih.gov/pubmed/28416951 http://dx.doi.org/10.4046/trd.2017.80.2.105 |
work_keys_str_mv | AT simyunsu spirometryandbronchodilatortest AT leejihyun spirometryandbronchodilatortest AT leewonyeon spirometryandbronchodilatortest AT suhdongin spirometryandbronchodilatortest AT ohyeonmok spirometryandbronchodilatortest AT yoonjongseo spirometryandbronchodilatortest AT leejinhwa spirometryandbronchodilatortest AT chojaehwa spirometryandbronchodilatortest AT kwoncheolseok spirometryandbronchodilatortest AT changjunghyun spirometryandbronchodilatortest |